Cormorant Asset Management, LP - 04 Dec 2023 Form 3 Insider Report for EyePoint Pharmaceuticals, Inc. (EYPT)

Role
10%+ Owner
Signature
/s/ CORMORANT ASSET MANAGEMENT, LP By: Bihua Chen, Managing Member
Issuer symbol
EYPT
Transactions as of
04 Dec 2023
Net transactions value
$0
Form type
3
Filing time
06 Dec 2023, 16:38:40 UTC
Previous filing
25 Oct 2023
Next filing
12 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding EYPT Common Stock 3,530,943 04 Dec 2023 See Footnotes F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Cormorant Asset Management, LP ("Cormorant") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the "Master Fund"). Cormorant Global Healthcare GP, LLC ("GP LLC") serves as General Partner of the Master Fund. Bihua Chen serves as manager of Cormorant, GP LLC. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 3 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose.
F2 Represents 3,530,943 shares beneficially owned by the Master Fund.